Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors

E-ISSN： 1873-5592|18|10|1171-1178

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.10, 2017-07, pp. : 1171-1178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapy for epithelial ovarian cancer

By Sharma Sameer Odunsi Kunle

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 501-513

Informa Healthcare

Access to resources Recommend Favorite

Targeted Gene Therapy for Ovarian Cancer

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 643-653

Bentham Science Publishers

Access to resources Recommend Favorite

From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer

By Góómez-Raposo Céésar Mendiola Marta Barriuso Jorge Hardisson David Redondo Andréés

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 591-594

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis Inhibitors: New Agents in Cancer Therapy

By Ryan C.J.

Drugs & Aging, Vol. 17, Iss. 4, 2000-10 ,pp. : 249-255

Adis International

Access to resources Recommend Favorite

Inhibitors of Angiogenesis in Cancer Therapy – Synthesis and Biological Activity

Current Medicinal Chemistry, Vol. 22, Iss. 33, 2015-11 ,pp. : 3830-18

Bentham Science Publishers

Access to resources Recommend Favorite